奋斗

小米春节即将来临：小米82099元礼券有限，小米手镯35%折扣…_我的网站

A |     Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。1月10日，雷迪今天在北京举行了一次新品牌发布会。

B | 雷军除了宣布红米纸条7外，还宣布了小米春节的到来，其中包括一个8折和5折小米手镯2099元后收到的门票。其中，商场的很多商品收到票后价格都很优惠，包括：小米8 2099元，小米电视4A 55寸1999元，小米爱心喇叭迷你99元，小米照相打印机499元，小米网上洗衣烘干机1999元，小米手镯3折5个等等。

C | 红米记事本7也将在春节期间正式发布。Red Rice Note7配备“全血版”Mirong 660处理器，14nm工艺，2.2GHz主频，4000mAh电池配备新的石墨负极，支持QC 4协议。

D | 对于摄影，Red Rice Note7搭载4800万像素和500万像素的AI双摄像头，在1.6微米的大像素高灵敏度模式下在黑暗环境下自动四倍拍摄，以及超级夜景支持。雷军还介绍了红米饭的质量说明7，其中包括许多质量奖。机身采用四角保护设计，增强局部强度；键/接口防水设计，支持防溅；微裂纹边缘抛光工艺，增强韧性，增强抗压强度，手机也提供18个月的质量保证。红米注7、3、32GB为999元，4、64GB为1199元，6、64GB为1399元，1月15日上午10点出售。

E | 小米北京东历新年，11:00:00:00正式开幕，进入会场。

Current article:http://0oazv.mexuanmeixuyaopinzheng.shop/zfxx/20260826/272.html

Published on:06:41:29